Cite Filings / ALLO
Feed Companies Filings Check
Sign in

CIK 0001737287 · Non-accelerated filer<br>Smaller reporting company

Allogene Therapeutics, Inc.

Sign in to watch
Ticker
ALLO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
823562771
Phone
(650) 457-2700
Business address
210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
Filings Insiders Search text
All 587 Financials 121 Shareholder Meetings 10 Executive Compensation 104 Insider Trading 275 Beneficial Ownership Interest 77 Business Combinations 90 Public Offerings 28 Mutual Funds and ETFs 8 Others 81
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-04-30
  3. PRE 14A Proxy Proxy Statement (Preliminary) 2026-04-20
  4. DEF 14A Proxy Proxy Statement 2025-04-30
  5. DEF 14A Proxy Proxy Statement 2024-04-23
  6. DEF 14A Proxy Proxy Statement 2023-04-24
  7. DEF 14A Proxy Proxy Statement 2022-04-26
  8. PRE 14A Proxy Proxy Statement (Preliminary) 2022-04-14
  9. DEF 14A Proxy Proxy Statement 2021-04-22
  10. DEF 14A Proxy Proxy Statement 2020-04-23
  11. DEF 14A Proxy Proxy Statement 2019-04-24

Page 1 of 1 · 10 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…